Researchers explored the potential of artificial intelligence for accelerating evidence generation, advancing disparities research, and improving trial design during a plenary session on the final day of the AACR Annual Meeting 2024.

Sundar Jagannath, MD, and other presenters discussed emerging results on immunotherapy approaches beyond immune checkpoint inhibitors during a clinical trials plenary session.

Deborah J. Wong, MD, PhD, and other speakers presented findings on novel combinations of immune checkpoint inhibitors during a clinical trials plenary session.

Sarah-Maria Fendt, PhD, and other researchers tackled the evolution of the genome, microenvironment, and host through metastasis during a plenary session.

AACR Immediate Past President Philip D. Greenberg, MD, FAACR, explored his own continuing experience with engineering T cells to eradicate tumors during a lecture at the Annual Meeting.

Titia de Lange, PhD, FAACR, was recognized with the Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research and presented a lecture on telomeres and cancer, including tumor suppression and genome instability.